Advertisement
Advertisement
APVO
Aptevo Therapeutics Inc
2.46
USDSponsored
+0.05
+2.07%
Aug 25, 15:59 UTC -4
Closed
Pre-Market
2.50
+0.04
+1.83%
APVO Earnings Reports
Positive Surprise Ratio
APVO beat 23 of 38 last estimates.
61%
Next Report
Date of Next Report
Nov 04, 2026
Estimate for Q3 26 (Revenue/ EPS)
--
/-$5.78
Implied change from Q2 26 (Revenue/ EPS)
--
/--
Implied change from Q3 25 (Revenue/ EPS)
--
/-82.73%
Aptevo Therapeutics Inc earnings per share and revenue
On Aug 10, 2026, APVO reported earnings of -- USD per share (EPS) for Q2 26, -- the estimate of -6.13 USD, resulting in a --% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference.
Looking ahead to Q3 26, -- analysts forecast an EPS of -5.78 USD, with revenue projected to reach -- USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Elutia Inc. Class A Common Stock
Report Date
Aug 13, 2026 For Q2 26
Estimate
-$0.15
Actual
-$0.17
Surprise
-11.11%
Lantern Pharma Inc. Common Stock
Report Date
Aug 14, 2026 For Q2 26
Estimate
-$0.38
Actual
-$0.28
Surprise
+27.76%
EVOGENE LTD.
Report Date
Aug 18, 2026 For Q2 26
Estimate
-$0.27
Actual
-$0.13
Surprise
+52.80%
Alvotech Ordinary Shares
Report Date
Aug 19, 2026 For Q2 26
Estimate
-$0.02
Actual
-$0.11
Surprise
-300.00%
Cabaletta Bio, Inc. Common Stock
Report Date
Aug 13, 2026 For Q2 26
Estimate
-$0.38
Actual
-$0.34
Surprise
+10.69%
Abeona Therapeutics Inc. Common Stock
Report Date
Aug 13, 2026 For Q2 26
Estimate
-$0.23
Actual
-$0.35
Surprise
-49.19%
Prenetics Global Limited Class A Ordinary Share
Report Date
Aug 18, 2026 For Q2 26
Estimate
-$0.71
Actual
-$0.53
Surprise
+26.30%
Fate Therapeutics, Inc.
Report Date
Aug 13, 2026 For Q2 26
Estimate
-$0.27
Actual
-$0.25
Surprise
+8.49%
ProMIS Neurosciences Inc. Common Shares (ON)
Report Date
Aug 13, 2026 For Q2 26
Estimate
-$1.39
Actual
-$1.28
Surprise
+8.07%
TuHURA Biosciences, Inc. Common Stock
Report Date
Aug 14, 2026 For Q2 26
Estimate
-$0.14
Actual
-$0.14
Surprise
+5.34%
FAQ
What were Aptevo Therapeutics Inc's earnings and revenue for the latest quarter Q2 2026?
For Q2 2026, Aptevo Therapeutics Inc reported EPS of --, missing estimates by --, and revenue of --, 0% as expectations.
How did the market react to Aptevo Therapeutics Inc's Q2 2026 earnings?
The stock price moved -- --, changed from -- before the earnings release to -- the day after.
When is Aptevo Therapeutics Inc expected to report next?
The next earning report is scheduled for Nov 04, 2026.
What are the forecasts for Aptevo Therapeutics Inc's next earnings report?
Based on --
analysts, Aptevo Therapeutics Inc is expected to report EPS of -$5.78 and revenue of -- for Q3 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement